In Vitro Activities of the Novel Cephalosporin LB 11058 against Multidrug-Resistant Staphylococci and Streptococci

LB 11058 is a novel parenteral cephalosporin with a C-3 pyrimidinyl-substituted vinyl sulfide group and a C-7 2-amino-5-chloro-1,3-thiazole group. This study evaluated the in vitro activity and spectrum of LB 11058 against 1,245 recent clinical isolates, including a subset of gram-positive strains w...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Sader, Helio S., Johnson, David M., Jones, Ronald N.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2004
Assuntos:	Susceptibility
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC310188/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14693518/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.1.53-62.2004
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!